The investment firm highlights a specific company expected to lead market returns over the coming years, based on long-term growth trajectories and sector tailwinds.

Jim Cramer has endorsed Netflix as a worthwhile investment risk after Wolfe Research raised its price target to $95, citing strong streaming fundamentals and content strategy.

Wolfe Research reaffirms its bullish outlook on SpaceX stock, citing the company's ongoing expansion of launch operations and sustained demand for its space services.

Netflix shares climbed after Wolfe Research upgraded its price target for the streaming giant to $95. This positive outlook positions Netflix favorably against competitors like Disney and Warner Bros. Discovery.

Wolfe Research advises investors to overlook recent concerns regarding Netflix's audience metrics, forecasting a stock rebound driven by stabilizing and improving viewer engagement trends.

Multiple investment firms, including DA Davidson, H.C. Wainwright, Stifel, TD Cowen, Wolfe Research, and JPMorgan, have reiterated or initiated stock ratings for various companies. These ratings are based on strong financial results, trial enrollments, earnings outlooks, and market developments.

Wolfe Research projects a flat outlook for CNH Industrial stock through 2027, attributing the stagnant forecast to current commodity prices.

Ian Lyngen, Head of US Rates Strategy at BMO Capital Markets, and Stephanie Roth, Chief Economist at Wolfe Research, join Scarlet Fu on "Bloomberg Real Yield." US Treasuries fell a day after the…

Wolfe Research suggests investing in durable stocks that have reported better-than-expected earnings, as the stock market navigates choppy waters in July, making fundamentally strong companies more appealing.

Wolfe Research has begun its coverage of Solaris Energy (SEI).

Wolfe Research has downgraded Simon Property Group (SPG) stock, explaining the rationale behind the revised rating.

Wolfe Research has upgraded Kimco Realty (KIM) due to its strong fundamentals and reduced refinancing risk. This positive assessment reflects confidence in the company's financial health and market position.

Wolfe Research has reiterated its bullish stance on Arista Networks (ANET), setting a price target of $175 for the stock.

Palantir is in focus after Wolfe Research issued a 'Peer Perform' rating, drawing attention to the company's opportunities in artificial intelligence.

Wolfe Research highlights SpaceX's 'out-of-this-world' valuation, attributing it to the company's near-monopoly in the rocket launch business.

Wolfe Research has issued a report weighing in on the stock performance of West Pharmaceutical Services Inc (WST).

Wolfe Research has reaffirmed its 'Outperform' rating on Amazon (AMZN), noting the potential for significant growth in the company's supply chain operations.

Wolfe Research forecasts that the market for CPUs will expand by 30% through 2028, driven by the increasing demand from artificial intelligence workloads.

Wolfe Research has screened for companies with market capitalizations exceeding $250 million that also rank in the top quintile for their net cash-to-market cap ratio, indicating strong financial health.

Wolfe Research has issued a warning about potential risks posed by central bank policies, particularly as oil prices continue to remain elevated. The analysis suggests a complex interplay between monetary policy and commodity markets.

Wolfe Research maintains a 'buy' rating on Five Below, setting a $291 price target and suggesting a potential 26% surge in shares, partly due to the company's focus on popular products.

Wolfe Research suggests that companies with a consistent history of buying back their own stock can provide investors with a strategic advantage during volatile market periods.

Wolfe Research has upgraded its rating for Brinker International (EAT), the parent company of Chili's and Maggiano's Little Italy, to 'Outperform'.

Wolfe Research has highlighted its preferred dividend stocks, noting that market volatility has boosted their appeal, and provided a list of buy ideas.

Wolfe Research has noted conviction-driven opportunities within ACADIA Pharmaceuticals Inc.’s (ACAD) therapeutic domains, suggesting potential for growth.

Wolfe Research has adopted a bearish stance on Circle Internet Group (CRCL), citing lower EBITDA expectations.

Analysts cite the midstream energy company's strong fundamentals and consistent growth trajectory as key drivers for the positive rating shift.

Shares of major vaccine manufacturers Moderna and BioNTech fell despite receiving positive ratings from Wolfe Research, highlighting broader market volatility in the biotech sector.

Wolfe Research has upgraded its rating for DT Midstream stock, citing positive long-term growth prospects in the utility sector.

Multiple financial institutions have adjusted their stock price targets for various companies, reflecting changes in market valuations, acquisition news, and financial outlooks. These adjustments include both increases and decreases across different sectors.

PulteGroup shares experienced a rise after Wolfe Research upgraded the stock rating, citing a positive outlook on the company's margins. This upgrade reflects confidence in PulteGroup's financial performance.

Wolfe Research has downgraded its stock rating for HubSpot, citing concerns over the company's weaker growth prospects.

Wolfe Research has upgraded AT&T, citing improving fundamentals that are outweighing competitive risks for the telecommunications giant.

Wolfe Research suggests that Meta's potential expansion into AI cloud services could significantly increase its earnings.

Wolfe Research has identified a list of stocks that are at risk of lowering or eliminating their dividend payouts to shareholders, prompting a warning for investors.

Chevron's stock received an upgrade from Wolfe Research, citing a strong cash flow outlook for the energy giant.

Wolfe Research has turned bullish on Target, citing improvements in the retailer's operational execution as a key factor.

Wolfe Research has issued an Underperform rating for Avantor (AVTR), indicating a cautious outlook on the company's stock performance.

Wolfe Research predicts that market leadership will remain concentrated through 2026, indicating a continued focus on a limited number of dominant companies or sectors.

Micron's stock has surged by 223% this year, with Wolfe Research indicating further upside potential, prompting questions about whether this represents a brilliant setup or a recipe for disaster.

Wolfe Research has downgraded its rating for Boston Scientific Corporation (BSX) to 'Peer Perform' from its previous assessment.

Wolfe Research maintains a bullish outlook on Eli Lilly and Company, citing strong prospects for its pipeline of obesity drugs and potential market growth.

Wolfe Research has identified DoorDash (DASH) as one of its top stock picks. This recommendation highlights the firm's positive outlook on the food delivery company.

Wolfe Research reports that ongoing uncertainty surrounding COVID-19 continues to negatively impact the financial outlook for pharmaceutical giant Pfizer (PFE).

Wolfe Research has reduced its price target for ServiceNow (NOW) stock.

According to Wolfe Research, the adoption of artificial intelligence is growing, but its implementation remains primarily focused within specific industry sectors.

Wolfe Research has initiated coverage of BeOne Medicines AG (ONC) with an "Outperform" rating.

Following analysts' suggestions that Nvidia's $1 trillion orders guidance is a floor, not a ceiling, market sentiment indicates that the company's rally is expected to continue with significant future growth.

Wolfe Research has downgraded Starbucks to a neutral rating, citing an increasingly competitive coffee market.

Wolfe Research has identified several stocks with consistent dividend payments and solid track records, suggesting they could become dividend aristocrats amidst market volatility.

Analysts lowered their rating on Intuit stock, warning that slowing adoption and revenue growth in the company's core tax preparation segment may impact future earnings.

Wolfe Research chief economist Stephanie Roth expects cooling economic data ahead, suggesting the Federal Reserve can credibly avoid raising interest rates at its September meeting.

Investment firm Wolfe Research has upgraded its rating on Moderna shares, citing strong prospects for the company's mRNA technology platform and upcoming clinical developments.

Investment analysts have raised their price targets for Merck shares after clinical data demonstrated promising efficacy for the company's oncology pipeline, boosting investor confidence.

Analysts at Wolfe Research have upgraded their outlook on Nvidia, citing strong fundamentals and leadership in the artificial intelligence semiconductor market.

Wolfe Research has issued a warning that corporate spending on artificial intelligence initiatives could face pressure due to the impact of rising bond yields.

Wolfe Research has issued a positive outlook, anticipating strong earnings momentum for the S&P 500 index.

Wolfe Research has increased its stock price target for Remitly, citing margin expansion as the primary reason for the adjustment.

Wolfe Research has expressed wariness regarding Pentair plc, despite its status as a top UK dividend growth stock, raising questions about its future performance.

Wolfe Research has maintained its 'Outperform' rating on CoreWeave, signaling a positive outlook for the company's stock performance.

A battered oil major has received a 'buy' recommendation from Wolfe Research, indicating potential for recovery in its stock.

Wolfe Research has identified Palantir Technologies (PLTR) as a leader in enterprise AI, despite its premium valuation, according to a recent report.

Wolfe Research suggests investors play defense with dividend-paying companies that have a consistent 10-year track record of repurchasing their own shares.

Wolfe Research has begun its coverage of Super Micro Computer (SMCI) stock, providing initial analysis and recommendations for investors.

Wolfe Research has increased its price target for Micron Technology (MU) stock.

Wolfe Research has downgraded Danaher Corporation (DHR), indicating a revised outlook on the company's stock performance.

Wolfe Research has begun coverage of Tyra Biosciences, Inc. (TYRA) with a 'Peer Perform' rating.

Wolfe Research has shifted to a more defensive position on risk assets, citing increasing yield pressures in the market. This strategic adjustment reflects concerns over current economic conditions.

Wolfe Research has reiterated its focus on Nvidia's leading position in artificial intelligence, emphasizing the company's continued dominance in the sector.

Wolfe Research suggests that the market's reaction to Eli Lilly's (LLY) Foundayo report appears to be excessive, indicating a potential overcorrection in the stock price.

Wolfe Research has reportedly lifted its price target for Moody's (MCO) stock, indicating a positive outlook for the company's shares.

Wolfe Research has expressed a bullish outlook on The Home Depot, Inc. (HD), even amidst a general market downturn.

Wolfe Research has reiterated its "Buy" rating for Nvidia (NVDA), signaling continued confidence in the technology company's stock performance.

Fastenal (FAST) has been included in Wolfe Research's favorites list, identified as a key play in the ongoing manufacturing recovery.

Wolfe Research has increased its price target for Amazon, attributing the positive outlook to the strong performance of its AWS business, particularly from investments in AI and data centers.

Off-price retailers, such as Dollar General, are anticipated to be most severely affected by a projected surge in gasoline prices, according to Wolfe Research, which could impact consumer spending habits.

Several financial firms have issued new ratings, price targets, or coverage initiations for biotech and pharmaceutical companies including Beam Therapeutics, Krystal Biotech, 4D Molecular Therapeutics, BioMarin Pharmaceutical, Vertex Pharmaceuticals, CRISPR Therapeutics AG, Regeneron Pharmaceuticals, and UniQure.

Wolfe Research has reiterated its 'Outperform' rating for RTX Corp following the company's deal with the Pentagon for a missile manufacturing framework.